help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cavailles, V.
Right arrow Articles by Rochefort, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cavailles, V.
Right arrow Articles by Rochefort, H.

Molecular Endocrinology, Vol 3, 552-558, Copyright © 1989 by Endocrine Society


ARTICLES

Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells

V Cavailles, M Garcia and H Rochefort
Unite Hormones et Cancer, INSERM, Montpellier, France.

In MCF7 human breast cancer cells, cathepsin-D and pS2 mRNAs are specifically and directly induced by estrogens at the transcriptional level. We studied the regulation of expression of these two genes by growth factors that are also mitogenic in this cell line. We show that pS2 mRNA, like cathepsin-D mRNA, is rapidly induced 2- to 4-fold by epidermal growth factor. The effect of epidermal growth factor on these two mRNAs was dependent upon de novo protein synthesis, indicating a different mechanism of regulation than with estradiol. Other peptide growth factors, such as insulin, insulin-like growth factor I, and basic fibroblast growth factor, also increased up to 3-fold the steady state levels of the two mRNAs in MCF7 cells. The pS2 mRNA, but not cathepsin-D mRNA, was also induced up to 8-fold by protein kinase-C activation with 12-O-tetradecanoylphorbol-13-acetate, suggesting the possible involvement of this transduction pathway in pS2 mRNA induction. The effect of 12-O-tetradecanoylphorbol-13-acetate was time and dose dependent and required protein synthesis. In addition, treatment by agents elevating cAMP increased pS2 mRNA accumulation 4- fold, whereas it had no effect on cathepsin-D mRNA levels. These results demonstrate that cathepsin-D and pS2 genes are under complex regulation in MCF7 cells, since growth factors stimulate their expression via indirect mechanisms contrasting with the primary transcriptional effects of estrogens.


This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
B. Tan, X. Long, H. Nakshatri, K. P Nephew, and R. M Bigsby
Striatin-3{gamma} inhibits estrogen receptor activity by recruiting a protein phosphatase
J. Mol. Endocrinol., May 1, 2008; 40(5): 199 - 210.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Baron, A. Escande, G. Alberola, K. Bystricky, P. Balaguer, and H. Richard-Foy
Estrogen Receptor {alpha} and the Activating Protein-1 Complex Cooperate during Insulin-like Growth Factor-I-induced Transcriptional Activation of the pS2/TFF1 Gene
J. Biol. Chem., April 20, 2007; 282(16): 11732 - 11741.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Vivacqua, D. Bonofiglio, L. Albanito, A. Madeo, V. Rago, A. Carpino, A. M. Musti, D. Picard, S. Ando, and M. Maggiolini
17beta-Estradiol, Genistein, and 4-Hydroxytamoxifen Induce the Proliferation of Thyroid Cancer Cells through the G Protein-Coupled Receptor GPR30
Mol. Pharmacol., October 1, 2006; 70(4): 1414 - 1423.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. Augereau, E. Badia, M. Fuentes, F. Rabenoelina, M. Corniou, D. Derocq, P. Balaguer, and V. Cavailles
Transcriptional Regulation of the Human NRIP1/RIP140 Gene by Estrogen Is Modulated by Dioxin Signalling
Mol. Pharmacol., April 1, 2006; 69(4): 1338 - 1346.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. Vivacqua, D. Bonofiglio, A. G. Recchia, A. M. Musti, D. Picard, S. Ando, and M. Maggiolini
The G Protein-Coupled Receptor GPR30 Mediates the Proliferative Effects Induced by 17{beta}-Estradiol and Hydroxytamoxifen in Endometrial Cancer Cells
Mol. Endocrinol., March 1, 2006; 20(3): 631 - 646.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
S Zhang, X Li, R Burghardt, R Smith III, and S H Safe
Role of estrogen receptor (ER) {alpha} in insulin-like growth factor (IGF)-I-induced responses in MCF-7 breast cancer cells
J. Mol. Endocrinol., December 1, 2005; 35(3): 433 - 447.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. T. Chatterton Jr., A. S. Geiger, E. T. Mateo, I. B. Helenowski, and P. H. Gann
Comparison of Hormone Levels in Nipple Aspirate Fluid of Pre- and Postmenopausal Women: Effect of Oral Contraceptives and Hormone Replacement
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1686 - 1691.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Maggiolini, A. Vivacqua, G. Fasanella, A. G. Recchia, D. Sisci, V. Pezzi, D. Montanaro, A. M. Musti, D. Picard, and S. Ando
The G Protein-coupled Receptor GPR30 Mediates c-fos Up-regulation by 17{beta}-Estradiol and Phytoestrogens in Breast Cancer Cells
J. Biol. Chem., June 25, 2004; 279(26): 27008 - 27016.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Khan, M. Abdelrahim, I. Samudio, and S. Safe
Estrogen Receptor/Sp1 Complexes Are Required for Induction of cad Gene Expression by 17{beta}-Estradiol in Breast Cancer Cells
Endocrinology, June 1, 2003; 144(6): 2325 - 2335.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Demirpence, A. Semlali, J. Oliva, P. Balaguer, E. Badia, M.-J. Duchesne, J.-C. Nicolas, and M. Pons
An Estrogen-responsive Element-targeted Histone Deacetylase Enzyme Has an Antiestrogen Activity That Differs from That of Hydroxytamoxifen
Cancer Res., November 15, 2002; 62(22): 6519 - 6528.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. Nilsson, S. Makela, E. Treuter, M. Tujague, J. Thomsen, G. Andersson, E. Enmark, K. Pettersson, M. Warner, and J.-A. Gustafsson
Mechanisms of Estrogen Action
Physiol Rev, October 1, 2001; 81(4): 1535 - 1565.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
N. Suzumori, Y. Ozaki, M. Ogasawara, and K. Suzumori
Increased concentrations of cathepsin D in peritoneal fluid from women with endometriosis
Mol. Hum. Reprod., May 1, 2001; 7(5): 459 - 462.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. Samudio, C. Vyhlidal, F. Wang, M. Stoner, I. Chen, M. Kladde, R. Barhoumi, R. Burghardt, and S. Safe
Transcriptional Activation of Deoxyribonucleic Acid Polymerase {{alpha}} Gene Expression in MCF-7 Cells by 17{{beta}}-Estradiol
Endocrinology, March 1, 2001; 142(3): 1000 - 1008.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. Xie, R. Duan, I. Chen, I. Samudio, and S. Safe
Transcriptional Activation of Thymidylate Synthase by 17{beta}-Estradiol in MCF-7 Human Breast Cancer Cells
Endocrinology, July 1, 2000; 141(7): 2439 - 2449.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. Duan, W. Porter, I. Samudio, C. Vyhlidal, M. Kladde, and S. Safe
Transcriptional Activation of c-fos Protooncogene by 17{beta}-Estradiol: Mechanism of Aryl Hydrocarbon Receptor-Mediated Inhibition
Mol. Endocrinol., September 1, 1999; 13(9): 1511 - 1521.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
W. Xie, R. Duan, and S. Safe
Estrogen Induces Adenosine Deaminase Gene Expression in MCF-7 Human Breast Cancer Cells: Role of Estrogen Receptor-Sp1 Interactions
Endocrinology, January 1, 1999; 140(1): 219 - 227.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
T. Utsumi, N. Yoshimura, S. Takeuchi, J. Ando, M. Maruta, K. Maeda, and N. Harada
Steroid Sulfatase Expression Is an Independent Predictor of Recurrence in Human Breast Cancer
Cancer Res., January 1, 1999; 59(2): 377 - 381.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Roger, P. Pujol, A. Lucas, P. Baldet, and H. Rochefort
Increased Immunostaining of Fibulin-1, an Estrogen-Regulated Protein in the Stroma of Human Ovarian Epithelial Tumors
Am. J. Pathol., November 1, 1998; 153(5): 1579 - 1588.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
M Garcia, N Platet, E Liaudet, V Laurent, D Derocq, J. Brouillet, and H Rochefort
Biological and clinical significance of cathepsin D in breast cancer metastasis
Stem Cells, November 1, 1996; 14(6): 642 - 650.
[Abstract]


Home page
J. Biol. Chem.Home page
E. Castro-Rivera, I. Samudio, and S. Safe
Estrogen Regulation of Cyclin D1 Gene Expression in ZR-75 Breast Cancer Cells Involves Multiple Enhancer Elements
J. Biol. Chem., August 10, 2001; 276(33): 30853 - 30861.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Saville, H. Poukka, M. Wormke, O. A. Janne, J. J. Palvimo, M. Stoner, I. Samudio, and S. Safe
Cooperative Coactivation of Estrogen Receptor alpha in ZR-75 Human Breast Cancer Cells by SNURF and TATA-binding Protein
J. Biol. Chem., January 18, 2002; 277(4): 2485 - 2497.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society